Literature DB >> 1296592

Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera.

A van Lingen1, P C Huijgens, F C Visser, G J Ossenkoppele, O S Hoekstra, H J Martens, H Huitink, K D Herscheid, M V Green, G J Teule.   

Abstract

Line-source experiments were conducted to assess the performance of a gamma-camera equipped with a specially designed 511-keV collimator for the planar imaging of positron emitters. The results were compared with the camera performance with routinely used collimators and radionuclides (thallium-201, technetium-99m and gallium-67). With positron emitters, scatter contributed less to the widening of the line spread function than with radionuclides emitting lower photon energies. These observations can be explained by the relative deterioration in the discrimination power of the gamma-camera to reject scattered radiation at low energies. Planar 511-keV imaging may provide relevant clinical information, as we showed by fluorodeoxyglucose studies in a patient with a myocardial infarction and in a patient with a malignant lymphoma. It is concluded that positron emitters can be effectively applied for planar imaging with the generally available gamma-cameras. This study implies that radiotracers developed for positron emission tomography may find a place in the practice of conventional nuclear medicine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1296592     DOI: 10.1007/bf00177052

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

1.  Rapid and sensitive response of carbon-11-L-methionine tumor uptake to irradiation.

Authors:  K Kubota; T Matsuzawa; T Takahashi; T Fujiwara; S Kinomura; T Ido; T Sato; R Kubota; M Tada; K Ishiwata
Journal:  J Nucl Med       Date:  1989-12       Impact factor: 10.057

2.  Non-invasive detection of reduced regional myocardial perfusion at rest in patients with unstable angina pectoris: increased regional 81mKr deposition following intravenous injection of 81Rb.

Authors:  R Zimmermann; H Tillmanns; B Bubeck; F J Neumann; A Ernst; H Bihl; A Hanser; W Kübler
Journal:  Nuklearmedizin       Date:  1991-08       Impact factor: 1.379

3.  Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma.

Authors:  R Paul
Journal:  J Nucl Med       Date:  1987-03       Impact factor: 10.057

4.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

5.  Residual mass and negative gallium scintigraphy in treated lymphoma.

Authors:  O Israel; D Front; R Epelbaum; S Ben-Haim; J Jerushalmi; U Kleinhaus; E Even-Sapir; E Robinson
Journal:  J Nucl Med       Date:  1990-03       Impact factor: 10.057

6.  Uptake of gallium-67 citrate and [2-3H]deoxyglucose in the tumor model, following chemotherapy and radiotherapy.

Authors:  G Iosilevsky; D Front; L Bettman; R Hardoff; Y Ben-Arieh
Journal:  J Nucl Med       Date:  1985-03       Impact factor: 10.057

  6 in total
  18 in total

1.  Use of myocardial perfusion imaging to assess viability.

Authors:  M I Travin
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

Review 2.  Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues.

Authors:  V Dilsizian; S L Bacharach; M M Khin; M F Smith
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

3.  F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization.

Authors:  J J Bax; J H Cornel; F C Visser; P M Fioretti; J M Huitink; A van Lingen; G W Sloof; C A Visser
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

4.  Safety and feasibility of cardiac FDG SPECT following oral administration of Acipimox, a nicotinic acid derivative: Comparison of image quality with hyperinsulinemic euglycemic clamping in nondiabetic patients.

Authors:  Jeroen J Bax; Frans C Visser; Don Poldermans; Arthur Van Lingen; Abdou Elhendy; Eric Boersma; Gerrit W Sloof; Cees A Visser
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

5.  Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals.

Authors:  J J Bax; F C Visser; A van Lingen; A B Groeneveld; J M Huitink; G J Teule; C A Visser
Journal:  Eur J Nucl Med       Date:  1995-01

Review 6.  Fluorine 18-labeled fluorodeoxyglucose myocardial scintigraphy with Anger gamma cameras for assessing myocardial viability.

Authors:  M J Kelly; V Kalff
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

Review 7.  Where are we with nuclear medicine in pediatrics?

Authors:  H R Nadel
Journal:  Eur J Nucl Med       Date:  1995-12

8.  Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography.

Authors:  O S Hoekstra; A van Lingen; G J Ossenkoppele; R Golding; G J Teule
Journal:  Eur J Nucl Med       Date:  1993-12

9.  Pulsed wave tissue Doppler imaging for the quantification of contractile reserve in stunned, hibernating, and scarred myocardium.

Authors:  M Bountioukos; A F L Schinkel; J J Bax; V Rizzello; R Valkema; B J Krenning; E Biagini; E C Vourvouri; J R T C Roelandt; D Poldermans
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

10.  Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle, assessed by planar imaging.

Authors:  J M Huitink; F C Visser; G R van Leeuwen; A van Lingen; J J Bax; R J Heine; G J Teule; C A Visser
Journal:  Eur J Nucl Med       Date:  1995-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.